JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 12, 2006; DOI: 10.1124/jpet.105.096917


0022-3565/06/3172-473-479$20.00
JPET 317:473-479, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.096917v1
317/2/473    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grenz, A.
Right arrow Articles by Osswald, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grenz, A.
Right arrow Articles by Osswald, H.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Theophylline Improves Early Allograft Function in Rat Kidney Transplantation

Almut Grenz, Detlef Baier, Fotios Petroktistis, Manfred Wehrmann, Christoph Köhle, Martin Schenk, Michael Sessler, Christoph H. Gleiter, Fred Fandrich, and Hartmut Osswald

Departments of Pharmacology and Toxicology (A.G., D.B., C.K., C.H.G., H.O.), Oral and Maxillofacial Surgery (F.P.), Pathology (M.W.), and General Surgery (M.Sc., M.Se.), University Hospital Tuebingen, Tuebingen, Germany; and Department of General and Thoracic Surgery, University Hospital Kiel, Kiel, Germany (F.F.)

Several previous studies have demonstrated a beneficial effect of the adenosine receptor (AdoR) antagonist theophylline in different forms of acute renal failure in laboratory animals and in humans. Therefore, we wanted to test whether theophylline can also improve impaired allograft function following ischemia reperfusion injury in experimental kidney transplantation (KT). Orthotopic transplantation of the left kidney was performed from Fisher 344 into Lewis rats. All transplanted rats received daily cyclosporine (5 mg/kg). The effect of theophylline treatment (10 mg/kg) on graft function was compared with appropriate controls on day 5 after KT by assessment of glomerular filtration rate (GFR) (inulin clearance). On day 5, GFR of allografts in control rats was 0.23 ± 0.05 ml/min/g kidney weight (n = 10) compared with 0.50 ± 0.09 ml/min/g in rats receiving theophylline (n = 9, p < 0.01), representing a 2-fold increase in GFR. Renal AdoR A1 mRNA content was significantly increased in both KT groups compared with their respective control groups, whereas mRNA of AdoR A2a, A2b, and A3 were found to be unchanged. Theophylline did not affect significantly interstitial infiltration of the graft by monocytes/macrophages and T-cells. Likewise, serum cytokines [interleukin (IL)-2, IL-6, IL-10, tumor necrosis factor-{alpha}] and erythropoietin plasma levels were not different among the allograft groups. The present study demonstrates that theophylline remarkably improved early renal allograft function in rats undergoing KT without influencing cytokine serum patterns or tissue inflammation. Since theophylline is a commonly used medication in humans, clinical studies in patients undergoing KT are warranted.


Received for publication October 11, 2005
Accepted January 9, 2006.

Address correspondence to: Dr. Hartmut Osswald, Institute of Pharmacology and Toxicology, Wilhelmstrasse 56, D-72074 Tuebingen, Germany. E-mail: hartmut.osswald{at}uni-tuebingen.de




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Grenz, H. Zhang, J. Weingart, S. von Wietersheim, T. Eckle, J. Schnermann, C. Kohle, D. Kloor, C. H. Gleiter, V. Vallon, et al.
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1501 - F1511.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.